Session XVIII: Predicting and Managing Rare Toxicities in GI Cancer Patients

Chair(s)

• 

  Sharlene Gill, MD, MPH, MBA

  BC Cancer - University of British Columbia
  Vancouver, Canada
• 

  Juan Manuel O'Connor, MD, MSc

  Instituto Alexander Fleming
  BUENOS AIRES, Argentina

Presentations:

• 18:05 – 18:13

  SO-29: Dihydropyrimidine dehydrogenase (DPD) genotype and phenotype among Danish cancer patients: Prevalence and correlation between DPYD-genotype mutations and P-uracil concentrations
  

  Abstract Presenter: Niels Paulsen
• 18:13 – 18:21

  SO-30: Impact of single heterozygous UGT1A1 on the clinical outcomes of nano-liposomal irinotecan plus 5-fluorouracil/leucovorin for patients with pancreatic ductal adenocarcinoma
  

  Abstract Presenter: Kazuaki Harada
• 18:41 – 19:00

  Cardiac Toxicities
  

  Speaker: Pia Osterlund, MD PhD Prof – Tampere university hospital and Karolinska Hospital/Institutet